The Principal Investigator and Program Director of this Calabresi Scholars Program, Dr. Edward Sausville, joined UMGCC in May 2004 following a 20-year career in the U.S. Public Health Service at the NIH. He earned his B.S. in Biochemistry from Manhattan College in 1973, and his Ph.D. in Pharmacology and M.D. in 1979 from Albert Einstein College of Medicine of Yeshiva University in New York. He trained in Internal Medicine at Brigham and Women’s Hospital, and in Medical Oncology at the National Cancer Institute. A medical oncologist and pharmacologist, Dr. Sausville is a recognized leader in all aspects of cancer drug discovery and development, from screening and selection of leads through formulation and safety testing and Phase I – III clinical trial design and implementation. His research interests have been related to the molecular mechanisms of novel anti-neoplastic agent action, and clinical studies of novel cancer therapies. Click here for more information on Dr. Sausville’s research interests.
Each Calabresi Scholar will have three mentors: a clinical mentor, a basic science mentor, and a biostatistical mentor. Although we cannot guarantee that any particular faculty member will be available to serve as a mentor, we encourage potential Scholars to explore the broad range of research interests pursued by UMGCC faculty.